Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2, Randomized, Double-Blind, Placebo and Active-Controlled Trial of LY2951742 in Patients With Mild to Moderate Osteoarthritis Pain of the Knee

NCT02192190 is registered in ClinicalTrials.gov with Eli Lilly and Company as lead sponsor.

NCT NCT02192190
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02192190 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2, Randomized, Double-Blind, Placebo and Active-Controlled Trial of LY2951742 in Patients With Mild to Moderate Osteoarthritis Pain of the Knee
Lead sponsor
Eli Lilly and Company
Phase
Phase 2
Overall status
Terminated
Start date
July 31, 2014
Completion date
June 30, 2015
Enrollment
268 (actual)
Sites
38

Conditions

As the registry lists them; a condition with its own page is linked.

osteoarthritis, knee